Literature DB >> 29982964

Prion-Like Propagation of Post-Translationally Modified Tau in Alzheimer's Disease: A Hypothesis.

Shweta Kishor Sonawane1,2, Subashchandrabose Chinnathambi3,4.   

Abstract

The microtubule-associated protein Tau plays a key role in the neuropathology of Alzheimer's disease by forming intracellular neurofibrillary tangles. Tau in the normal physiological condition helps stabilize microtubules and transport. Tau aggregates due to various gene mutations, intracellular insults and abnormal post-translational modifications, phosphorylation being the most important one. Other modifications which alter the function of Tau protein are glycation, nitration, acetylation, methylation, oxidation, etc. In addition to forming intracellular aggregates, Tau pathology might spread in a prion-like manner as revealed by several in vitro and in vivo studies. The possible mechanism of Tau spread can be via bulk endocytosis of misfolded Tau species. The recent studies elucidating this mechanism have mainly focussed on the aggregation and spread of repeat domain of Tau in the cell culture models. Further studies are needed to elucidate the prion-like propagation property of full-length Tau and its aggregates in a more intense manner in vitro as well as in vivo conditions. Varied post-translational modifications can have discrete effects on aggregation propensity of Tau as well as its propagation. Here, we review the prion-like properties of Tau and hypothesize the role of glycation in prion-like properties of Tau. This post-translationally modified Tau might have an enhanced propagation property due to differential properties conferred by the modifications.

Entities:  

Keywords:  Alzheimer disease; Post-translational modifications of tau; Propagation of tau; Tau; Tauopathies

Mesh:

Substances:

Year:  2018        PMID: 29982964     DOI: 10.1007/s12031-018-1111-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  104 in total

1.  Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property.

Authors:  Kefu Liu; Yutong Liu; Lingyun Li; Peibin Qin; Javed Iqbal; Yulin Deng; Hong Qing
Journal:  Biochim Biophys Acta       Date:  2015-12-02

2.  Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure.

Authors:  O Schweers; E Schönbrunn-Hanebeck; A Marx; E Mandelkow
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

3.  Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.

Authors:  E M Mandelkow; G Drewes; J Biernat; N Gustke; J Van Lint; J R Vandenheede; E Mandelkow
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

Review 4.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

Authors:  Diane P Hanger; Brian H Anderton; Wendy Noble
Journal:  Trends Mol Med       Date:  2009-02-24       Impact factor: 11.951

5.  Analysis of microtubule-associated protein tau glycation in paired helical filaments.

Authors:  M D Ledesma; P Bonay; C Colaço; J Avila
Journal:  J Biol Chem       Date:  1994-08-26       Impact factor: 5.157

6.  Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons.

Authors:  Jessica W Wu; Mathieu Herman; Li Liu; Sabrina Simoes; Christopher M Acker; Helen Figueroa; Joshua I Steinberg; Martin Margittai; Rakez Kayed; Chiara Zurzolo; Gilbert Di Paolo; Karen E Duff
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

7.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

8.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

9.  A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits.

Authors:  S L Shyng; J E Heuser; D A Harris
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

10.  Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.

Authors:  Ksenia Kurbatskaya; Emma C Phillips; Cara L Croft; Giacomo Dentoni; Martina M Hughes; Matthew A Wade; Safa Al-Sarraj; Claire Troakes; Michael J O'Neill; Beatriz G Perez-Nievas; Diane P Hanger; Wendy Noble
Journal:  Acta Neuropathol Commun       Date:  2016-03-31       Impact factor: 7.801

View more
  16 in total

Review 1.  Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease.

Authors:  Abhishek Ankur Balmik; Subashchandrabose Chinnathambi
Journal:  Cell Commun Signal       Date:  2021-05-07       Impact factor: 5.712

Review 2.  Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.

Authors:  Congcong Zhang; Rina M Ötjengerdes; Julian Roewe; Rebeca Mejias; Andrea L J Marschall
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807

3.  Photoexcited Toluidine Blue Inhibits Tau Aggregation in Alzheimer's Disease.

Authors:  Tushar Dubey; Nalini Vijay Gorantla; Kagepura Thammaiah Chandrashekara; Subashchandrabose Chinnathambi
Journal:  ACS Omega       Date:  2019-10-29

Review 4.  Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review.

Authors:  Jorge Berlanga-Acosta; Gerardo Guillén-Nieto; Nadia Rodríguez-Rodríguez; Maria Luisa Bringas-Vega; Diana García-Del-Barco-Herrera; Jorge O Berlanga-Saez; Ariana García-Ojalvo; Mitchell Joseph Valdés-Sosa; Pedro A Valdés-Sosa
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-05       Impact factor: 5.555

5.  Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation.

Authors:  Shweta Kishor Sonawane; Vladimir N Uversky; Subashchandrabose Chinnathambi
Journal:  Cell Commun Signal       Date:  2021-02-12       Impact factor: 5.712

Review 6.  Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer's disease.

Authors:  Smita Eknath Desale; Subashchandrabose Chinnathambi
Journal:  Cell Commun Signal       Date:  2021-02-24       Impact factor: 5.712

7.  The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice.

Authors:  Jing Di; Ibrar Siddique; Zizheng Li; Ghattas Malki; Simon Hornung; Suman Dutta; Ian Hurst; Ella Ishaaya; Austin Wang; Sally Tu; Ani Boghos; Ida Ericsson; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan
Journal:  Alzheimers Res Ther       Date:  2021-01-04       Impact factor: 8.823

Review 8.  Abnormal Homocysteine Metabolism: An Insight of Alzheimer's Disease from DNA Methylation.

Authors:  Tingting Pi; Bo Liu; Jingshan Shi
Journal:  Behav Neurol       Date:  2020-09-08       Impact factor: 3.342

Review 9.  Role of dietary fatty acids in microglial polarization in Alzheimer's disease.

Authors:  Smita Eknath Desale; Subashchandrabose Chinnathambi
Journal:  J Neuroinflammation       Date:  2020-03-24       Impact factor: 8.322

10.  α- Linolenic acid modulates phagocytosis and endosomal pathways of extracellular Tau in microglia.

Authors:  Smita Eknath Desale; Subashchandrabose Chinnathambi
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.